...
首页> 外文期刊>Journal of Neural Transplantation and Plasticity: Neural Plasticity >Active Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Regulates NMDA Receptor Mediated Postischemic Long-Term Potentiation (i-LTP) by Promoting the Interaction between CaMKII and NMDA Receptors in Ischemia
【24h】

Active Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Regulates NMDA Receptor Mediated Postischemic Long-Term Potentiation (i-LTP) by Promoting the Interaction between CaMKII and NMDA Receptors in Ischemia

机译:活性钙/钙调蛋白依赖性蛋白激酶II(CAMKII)通过促进培养基中CAMKII和NMDA受体之间的相互作用来调节NMDA受体介导的出弱性长期增强(I-LTP)

获取原文
           

摘要

Active calcium/calmodulin-dependent protein kinase II (CaMKII) has been reported to take a critical role in the induction of long-term potentiation (LTP). Changes in CaMKII activity were detected in various ischemia models. It is tempting to know whether and how CaMKII takes a role in NMDA receptor (NMDAR)-mediated postischemic long-term potentiation (NMDA i-LTP). Here, we monitored changes in NMDAR-mediated field excitatory postsynaptic potentials (NMDA fEPSPs) at different time points following ischemia onsetin vitrooxygen and glucose deprivation (OGD) ischemia model. We found that 10 min OGD treatment induced significant i-LTP in NMDA fEPSPs, whereas shorter (3 min) or longer (25 min) OGD treatment failed to induce prominent NMDA i-LTP. CaMKII activity or CaMKII autophosphorylation displays a similar bifurcated trend at different time points following onset of ischemia bothin vitroOGD orin vivophotothrombotic lesion (PT) models, suggesting a correlation of increased CaMKII activity or CaMKII autophosphorylation with NMDA i-LTP. Disturbing the association between CaMKII and GluN2B subunit of NMDARs with short cell-permeable peptides Tat-GluN2B reversed NMDA i-LTP induced by OGD treatment. The results provide support to a notion that increased interaction between NMDAR and CaMKII following ischemia-induced increased CaMKII activity and autophosphorylation is essential for induction of NMDA i-LTP.
机译:据报道,活性钙/钙调蛋白依赖性蛋白激酶II(CAMKII)在长期增强(LTP)诱导中对关键作用。在各种缺血模型中检测到Camkii活动的变化。知道是否以及Camkii如何在NMDA受体(NMDAR)导明的短期增强(NMDA I-LTP)中是如何作用的诱人。在这里,我们在缺血vistroOxygen和葡萄糖剥夺(OGD)缺血模型中监测在不同时间点的NMDAR介导的现场兴奋性突触潜力(NMDA FEPSP)的变化。我们发现10分钟的OGD治疗在NMDA FEPSP中诱导了显着的I-LTP,而短(3分钟)或更长(25分钟)OGD治疗未能诱导突出的NMDA I-LTP。 Camkii Activity或Camkii自动磷酸化在缺血玻术患者血栓脱髓鞘病变(Pt)模型的发生后显示出不同时间点的相似的分叉趋势,表明CAMKII活性或CAMKII自身磷酸化合物与NMDA I-LTP的相关性。扰乱NMDARS与短电池渗透肽TAT-GLUN2B的CAMKII和GLUN2B亚基之间的关联逆转由OGD处理诱导的NMDA I-LTP。结果提供了对缺血诱导的CAMKII活性和自磷酸化诱导诱导NMDA I-LTP诱导必不可少的患有NMDAR和CAMKII之间的相互作用的观点的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号